Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))
Publication date
2022-05
Authors
Evers, Jelle
Hendriks, Lizza E.L.
De Jaeger, Katrien
Wijsman, Robin
De Ruysscher, Dirk
Terhaard, Chris H.J.
van der Sangen, Maurice
Siesling, Sabine
Struikmans, Henk
Aarts, Mieke J.
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
The authors would like to inform that in the original publication two rows stating ‘RT alone’ in Table 1 were included, whereas only the upper row regards ‘RT alone’ and the lower row regards ‘Chemotherapy alone’. Also, the percentages of patients receiving stereotactic body radiotherapy (SBRT) were calculated with the number of patients receiving any radiotherapy (excl. prophylactic cranial irradiation (PCI)) as denominator, which may be unclear in the original publication. The authors would like to apologise for any inconvenience caused.
Keywords
Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Published Erratum
Citation
Evers, J, Hendriks, L E L, De Jaeger, K, Wijsman, R, De Ruysscher, D, Terhaard, C, van der Sangen, M, Siesling, S, Struikmans, H & Aarts, M J 2022, 'Corrigendum to “Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019 : A nationwide population-based study from the Netherlands” [Lung Cancer 162C (2021) 61–70] (Lung Cancer (2021) 162 (61–70), (S0169500221005821), (10.1016/j.lungcan.2021.10.011))', Lung Cancer, vol. 167, pp. 107. https://doi.org/10.1016/j.lungcan.2021.12.012